https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32617 a priori hypotheses, and discriminative validity by discriminating subjects in different groups, respectively. To assess the applicability of HAQ in different regions, subgroup analyses were conducted for south and north China, respectively. Results: Questionnaires were administered to a consecutive sample of 133 RA patients. Cronbach's alpha showed a strong reliability among all the items. In particular, the internal reliability was higher when excluding the items about the use of aids and devices: 0.987 when excluding versus 0.963 when including. Construct validity was supported by achieving both of the a priori hypotheses based on correlations between the HAQ scores and scales of EQ-5D and SF-12. Overall, HAQ scores were important inferential factors for Global Functional Status in RA, which indicated good discriminative validity. The validation results are generally consistent between subgroups from north and south China. Conclusions: The Chinese HAQ demonstrated good acceptability and psychometric properties in RA patients from China. Two possible improvements for better use and interpretation of the patient-reported outcomes of RA patients in China could be to cross-culturally adapt the items about the use of aids and devices and joint use of mental health measurements together with HAQ in future studies.]]> Wed 23 Feb 2022 16:01:18 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53562 Wed 17 Apr 2024 13:46:49 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29597 Wed 13 Mar 2024 18:28:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16058 Wed 11 Apr 2018 17:17:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29809 Wed 11 Apr 2018 17:16:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30462 Wed 11 Apr 2018 15:33:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15109 Wed 11 Apr 2018 11:17:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22883 Wed 11 Apr 2018 11:04:47 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21660 Wed 11 Apr 2018 10:59:00 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19865 Wed 11 Apr 2018 10:07:52 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35104 Thu 28 Oct 2021 13:02:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38742 Thu 27 Jan 2022 16:10:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46476 n = 951), while confirmatory factor analysis (CFA) was used to assess the goodness-of-fit of EFA models for the remaining half (n = 951). Spearman correlations were used to assess the convergent validity of the SAS-SV, taking account of time spent by subjects on phones per day, the Smart Device Addiction Screening Tool (SDAST), the Pittsburgh Sleep Quality Index (PSQI), the Multidimensional Scale of Perceived Social Support (MSPSS), and the Center for Epidemiological Studies Depression Scale for Children (CES-DC). EFA generated a three-factor model (with factors labeled “dependency,” the incidence of a “problem,” and “time spent”). CFA confirmed this model yielded an acceptable goodness-of-fit (Comparative Fit Index = 0.96, Tucker Lewis Index = 0.95, and root-mean-square error of approximation = 0.06). SAS-SV was positively correlated with SDAST (ρ = 0.59), PSQI (ρ = 0.29), and CES-D (ρ = 0.35), and negatively correlated with MSPSS (ρ = −0.10). A linear regression model showed that female adolescents, those with highly educated caregivers and those who spent more time using smartphones on their holidays, had on average higher SAS-SV scores, meaning they showed greater vulnerability to becoming addicted. The study found that SAS-SV is a valid scale for estimating excessive smartphone use among Hong Kong children and adolescents.]]> Thu 24 Nov 2022 08:29:24 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36906 Thu 16 Jul 2020 12:26:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13265 Sat 24 Mar 2018 08:16:04 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20900 Sat 24 Mar 2018 07:57:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20987 QOLIE-10, whereas there were fewer predictors for HRQoL_EQ-5D or HRQoL_QWB-SA. Conclusions: QOLIE-10 appeared to be a reliable and sensitive instrument to assess the HRQoL for epilepsy patients. According to the MLR analyses, numbers of AEDs, refractory epilepsy, comorbidity depression, and cognitive function were demonstrated to be predictors of HRQoL dependent on different tools. Comparisons between the tools suggested epilepsy-specific instrument was more competent to discriminate HRQoL based on condition variables. However, a longitudinal study is still needed to examine the responsiveness of Chinese QOLIE-10.]]> Sat 24 Mar 2018 07:50:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5460 Sat 24 Mar 2018 07:48:11 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:6481 Sat 24 Mar 2018 07:47:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4888 Sat 24 Mar 2018 07:21:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:4870 Sat 24 Mar 2018 07:18:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52859 Mon 30 Oct 2023 10:01:56 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36021 Fri 24 Jan 2020 16:36:08 AEDT ]]>